IP Library Granted Patent US 12,258,469
Granted Patent B2
US 12,258,469 · App. 18/011,802 · Granted Mar 25, 2025

Aqueous biopolymer dispersions

Inventors: Alan Bewsher (Ripponden, GB); Paul Smith (Halifax, GB); Jade Rowley (Pontefract, GB)
Assignee: Aquaspersions Limited
C08L67/02C08J7/04C08J7/08C08K5/092C09D167/02C08J2301/02C08J2367/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,258,469
App. No.
18/011,802
Granted
Mar 25, 2025
Kind
B2
Abstract

An aqueous biopolymer dispersion composition comprising: a biopolymer selected from the group consisting of: polybutylene adipate terephthalate (PBAT), polybutylene succinate (PBS), polybutylene succinate adipate (PBSA), polylactic acid (PLA), poly(3-hydroxybutyrate) (PHB), polycaprolactone (PCL), poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBH); poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), polyhydroxyalkanoate (PHA), and mixtures thereof; a stabilising agent selected from the group consisting of: polyvinyl alcohol, fatty alcohol ethoxylates, ethylene oxide/propylene oxide (EO/PO) block copolymers, salts of fatty acids and mixtures thereof; a rheology modifier; a cross linking agent; optional further ingredients; and water.

Claims (36)

1. An aqueous biopolymer dispersion composition comprising:

a biopolymer selected from the group consisting of: polybutylene adipate terephthalate (PBAT), polybutylene succinate (PBS), polybutylene succinate adipate (PBSA), polylactic acid (PLA), poly (3-hydroxybutyrate) (PHB), polycaprolactone (PCL), poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBH);

poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), polyhydroxyalkanoate (PHA), and mixtures thereof;

a stabilising agent selected from the group consisting of: polyvinyl alcohol, fatty alcohol ethoxylates, ethylene oxide/propylene oxide (EO/PO) block copolymers, salts of fatty acids and mixtures thereof;

a rheology modifier;

a cross-linking agent being a bifunctional carboxylic acid or bifunctional aldehyde;

optional further ingredients; and

water.

2. The composition according to claim 1 , wherein the biopolymer is present in the dispersion in the amount of 10 wt % to 80 wt % based on the total weight of the aqueous dispersion.

3. The composition according to claim 1 , further comprising a wax or tackifier selected from the group consisting of: carnauba wax, beeswax, polyethylene, copolymers of polyethylene, oxidized polyethylene, copolymers of oxidized polyethylene, polyethers, lanolin, shellac, paraffin, candelilla, microcrystalline waxes, soy wax, montan wax, rosin ester, terpene resin, terpene-phenol resin, terpene phenol, pentaerythritol rosin ester, a modified terpene resin, a polyterpene, a phenol modified copolymer of styrene, and alpha methyl styrene, hydrocarbon resins and mixtures thereof.

4. The composition according to claim 3 , wherein the amount of wax is from 1 wt % to 12 wt %.

5. The composition of claim 3 , wherein the amount of wax is from 4wt % to 8wt %.

6. The composition according to claim 1 , wherein the stabilising agent is polyvinyl alcohol.

7. The composition according to claim 1 , wherein the stabilising agent is present in the dispersion in an amount of 1 wt % to 6 wt.

8. The composition according to claim 1 , wherein the rheology modifier is selected from the group consisting of: xanthan gum, cellulose ether, carboxy methyl cellulose, guar, polysaccharides, fully hydrolysed polyacrylic acid, polyurethane thickeners, and mixtures thereof.

9. The composition as claimed in claim 1 , wherein the cross-linking agent is selected from the group consisting of: oxalic acid, malonic acid, succinic acid, glutaric acid, pimelic acid, suberic acid, azelaic acid, sebacic acid, undecanedioic acid, dodecanedioic acid, brassylic acid, thapsic acid, japanic acid, phellogenic acid, equisetolic acid, maleic acid, fumaric acid, acetylene dicarboxylic acid, glutaconic acid, traumatic acid, muconic acid, glutinic acid, citraconic acid, mesaconic acid, itaconic acid, tartronic acid, mesoxalic acid, malic acid, tartaric acid, oxaloacetic acid, aspartic acid, α-hydroxyglutaric acid, arabinaric acid, acetone dicarboxylic acid, α-ketoglutaric acid, glutamic acid, diaminopimelic acid, saccharic acid, malondialdehyde, succinaldehyde, glutaraldehyde, isocitric acid, aconitric acid, propane-1,2,3-tricarboxylic acid, trimesic acid, and mixtures thereof.

10. The composition according to claim 1 , wherein the cross-linking agent is selected from the group consisting of: adipic acid, maleic acid, glyoxal, citric acid, and mixtures thereof.

11. The composition according to claim 1 , wherein the cross-linking agent is present in an amount of 0.05 wt % to 3 wt %.

12. A method of manufacture of a biopolymer coated cellulosic article comprises the steps of:

applying an aqueous biopolymer composition as according to claim 1 to a surface of a cellulosic substrate to form a coated substrate;

allowing water to vaporise from the coated substrate to form a dry coated substrate; and

heating the dry coated substrate to cure the composition to from a biopolymer film coated article.

13. A coated article comprising a cellulosic substrate coated with a film formed from a coating composition in accordance with claim 1 .

14. The composition of according to claim 1 , wherein the rheology modifier is an associative thickener.

15. The composition of claim 1 , wherein the stabilising agent is present in the dispersion in an amount of 2 wt % to 3 wt %.

16. An aqueous biopolymer dispersion composition comprising:

a biopolymer selected from the group consisting of: polybutylene adipate terephthalate (PBAT), polybutylene succinate (PBS), polybutylene succinate adipate (PBSA), polylactic acid (PLA), poly (3-hydroxybutyrate) (PHB), polycaprolactone (PCL), poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBH);

poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), polyhydroxyalkanoate (PHA), and mixtures thereof;

a stabilising agent selected from the group consisting of: polyvinyl alcohol, fatty alcohol ethoxylates, ethylene oxide/propylene oxide (EO/PO) block copolymers, salts of fatty acids and mixtures thereof;

a rheology modifier;

a cross-linking agent;

optional further ingredients; and

water, wherein the cross-linking agent is present in an amount of 0.05 wt % to 3 wt % of the composition.

17. The composition according to claim 16 , wherein the biopolymer is present in the dispersion in the amount of 10 wt % to 80wt %.

18. The composition according to claim 16 , wherein the stabilizing agent is polyvinyl alcohol.

19. A coated article comprising a cellulosic substrate coated with a film formed from a coating composition in accordance with claim 16 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2025
From: BEWSHER, ALAN
To: AQUASPERSIONS LTD.
Reel/Frame 070224/0064 →
Priority Claims (1)
EP 20183822 · Jul 2, 2020 · regional
Continuity (1)
Related Publication 20230235166A1 · Jul 27, 2023
References Cited (39)
US 5288318A · Mayer · 1994 [cited by examiner]
US 10047210B2 · Hernandez-Torres · 2018 [cited by examiner]
US 20110293957A1 · Johansson · 2011 [cited by examiner]
US 20130225761A1 · Whitehouse · 2013 [cited by examiner]
US 20170247537A1 · Hipps, Sr. · 2017 [cited by examiner]
US 20180171559A1 · Hipps, Sr. · 2018 [cited by examiner]
US 20200002572A1 · Spender · 2020 [cited by examiner]
US 20220010179A1 · Spender · 2022 [cited by examiner]
CN 104619748A · 2015 [cited by applicant]
CN 107163795A · 2017 [cited by applicant]
CN 107418170A · 2017 [cited by applicant]
CN 107698811A · 2018 [cited by applicant]
CN 109071828A · 2018 [cited by applicant]
CN 109867819A · 2019 [cited by examiner]
CN 110256919A · 2019 [cited by applicant]
CN 110885595A · 2020 [cited by applicant]
EP 2631060A1 · 2013 [cited by applicant]
EP 1566409B1 · 2016 [cited by applicant]
EP 3560996A1 · 2019 [cited by applicant]
FR 3076744B1 · 2021 [cited by applicant]
WO WO02085969A2 · 2002 [cited by applicant]
WO WO2005052075A1 · 2005 [cited by applicant]
WO WO2006120523A1 · 2006 [cited by applicant]
WO WO2008007919A1 · 2008 [cited by applicant]
WO WO2010013483A1 · 2010 [cited by applicant]
WO WO2014017715A1 · 2014 [cited by applicant]
WO WO2015059709A1 · 2015 [cited by applicant]
WO WO2016067285A1 · 2016 [cited by applicant]
WO WO2017151595A1 · 2017 [cited by applicant]
WO WO2018119083A1 · 2018 [cited by applicant]
WO WO2018184897A1 · 2018 [cited by applicant]
WO WO2018184898A1 · 2018 [cited by applicant]
WO WO2019094738A1 · 2019 [cited by applicant]
WO WO2020036843A1 · 2020 [cited by applicant]
WO WO2020242872A1 · 2020 [cited by applicant]
WO WO2022003195A1 · 2022 [cited by applicant]
International Search Report dated Oct. 25, 2021 issued in International Application No. PCT/EP2021/068418. [cited by applicant]
Written Opinion of the International Searching Authority dated Oct. 25, 2021 in International Patent Application No. PCT/EP2021/068418. [cited by applicant]
TW Examination report dated Nov. 12, 2024, issued in TW Application No. 110124502, with English Translation. [cited by applicant]